Drug pipeline
Full profile accessExplore the programs pursuing this target and their development progress.
- Drug candidates
- Developers
- Development stage
Target intelligence / Profile preview
Long intergenic non-protein coding RNA 2422 (LINC02422) is a human long intergenic non-coding RNA (lincRNA), meaning it is a non-protein-coding RNA transcript greater than 200 nucleotides in length and does not overlap protein-coding genes[1][3][7]. LINC02422 is registered in both NCBI Gene (Gene ID: 105369723) and Ensembl (ENSG00000255760)[1][3]. Long intergenic non-coding RNAs like LINC02422 commonly regulate gene expression by influencing chromatin structure, interacting with RNA-binding proteins, and modulating mRNA stability or transcription[5][7][9]. The specific functional role or pathological involvement of LINC02422 remains uncharacterized in the current literature, and there are no established small molecule or biologic drugs known to target it[1][3][5]. LINC02422 is not known to be a therapeutic target such as a receptor, enzyme, transporter, or similar molecule. Notes: - Biological functions listed (gene regulation, chromatin remodeling, etc.) are generalizable properties for lincRNAs as a class; there is no direct functional assignment to LINC02422 itself in currently available data[5][7][9]. - No disease association, biomarker application, or drug interaction has been specifically described for LINC02422 in public sources as of the current update[1][3]. - No evidence of misspelling or other metadata inaccuracies for LINC02422, but information is limited to genomic annotation; functional and clinical relevance is unconfirmed.
Beyond the preview
Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.
Explore the programs pursuing this target and their development progress.
Follow the clinical studies evaluating therapies directed at this target.
Compare approaches across drug candidates, modalities, and indications.
Investigate the research and source evidence behind target biology and development.
Explore patent activity around therapies and technologies addressing this target.
Connect target biology, drug development, and emerging evidence in your research.
See how Gosset can support your research on Long intergenic non-protein coding RNA 2422 (LINC02422).